Metabolic profiles show specific mitochondrial toxicities in vitro in myotube cells

Journal of Biomolecular NMR

Volumn 49, Issue 3-4, 2011, Pages 207-219

  Xu, Qiuwei ^a   Vu, Heather ^a   Liu, Liping ^a   Wang, Ting Chuan ^a   Schaefer, William H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Metabolomics; Mitochondria; NMR; Toxicity

Indexed keywords

ANTIMYCIN A1; ROTENONE;

ANIMAL CELL; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; FATTY ACID OXIDATION; METABOLOMICS; MITOCHONDRIAL RESPIRATION; MOUSE; MYOTUBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN;

ANTIMYCIN A; CELLS, CULTURED; CITRIC ACID CYCLE; ELECTRON TRANSPORT; HUMANS; METABOLOME; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; OXIDATIVE PHOSPHORYLATION; ROTENONE; UNCOUPLING AGENTS;

EID: 79958768677     PISSN: 09252738     EISSN: 15735001     Source Type: Journal    
DOI: 10.1007/s10858-011-9482-8     Document Type: Article

References (32)

1. Amacher DE (2005) Drug-associated mitochondrial toxicity and its detection. Curr Med Chem 12:1829-1839
2. Birch-Machin MA (2008) Assessment of mitochondrial respiratory complex function in vitro and in vivo. In: Will Y (ed) Drug-induced mitochondrial dysfunction. Wiley, London, pp 383-395
3. Chen C, Krausz KW, Shah YM, Idle JR, Gonzalez FJ (2009) Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem Res Toxicol 22:699-707
4. Ferrick D, Wu M, Swift A, Neilson A (2008) In: Will Y (ed) Drug-induced mitochondrial dysfunction. Wiley, London, pp 373-382
5. Fiehn O (2002) Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 48:155-171
6. Flynn NE, Meininger CJ, Haynes TE, Wu G (2002) The metabolic basis of arginine nutrition and pharmacotherapy. Biomed Pharmacother 56:427-438 (Pubitemid 35454030)
7. Kushmerick MJ, Moerland TS, Wiseman RW (1992) Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi. Proc Natl Acad Sci USA 89:7521-7525
8. Lee SJ (2003) Alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease? Antioxid Redox Signal 5:337-348
9. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Karppa M, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE (1998) Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 63:447-454 (Pubitemid 30418626)
10. Mortishire-Smith RJ, Skiles GL, Lawrence JW, Spence S, Nicholls AW, Johnson BA, Nicholson JK (2004) Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem Res Toxicol 17:165-173 (Pubitemid 38252496)
11. Nadanaciva S (2008) In: Will Y (ed) Drug-induced mitochondrial dysfunction. Wiley, London, pp 397-412
12. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96:2190-2196 (Pubitemid 27425822)
13. Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153-161 (Pubitemid 41646523)
14. Nieminen AL, Ramshesh VK, Lemasters JJ (2008) In: Will Y (ed) Drug-induced mitochondrial dysfunction. Wiley, London, pp 413-431
15. Ogg RJ, Kingsley PB, Taylor JS (1994) WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 104:1-10
16. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S (2002) Cytochrome c release from mitochondrial proceeds by a two-step process. Proc Natl Acad Sci USA 99:1259-1263 (Pubitemid 34136480)
17. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ, Young AB, Abagyan R, Feany MB, Hyman BT, Kazantsev AG (2007) Sirtuin 2 inhibitors rescue alpha-synuclein- mediated toxicity in models of Parkinson's disease. Science 317:516-519 (Pubitemid 47196116)
18. Pessayre D, Mansouri A, Berson A, Fromenty B (2010) Mitochondrial involvement in drug-induced liver injury. Handb Exp Pharmacol 196:311-365
19. Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85:809-822
20. Ross JM, Oberg J, Brene S, Coppotelli G, Terzioglu M, Pernold K, Goiny M, Sitnikov R, Kehr J, Trifunovic A, Larsson NG, Hoffer BJ, Olson L (2010) High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio. Proc Natl Acad Sci USA 107:20087-20092
21. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1:1269 (Pubitemid 19140359)
22. Schulze A (2003) Creatine deficiency syndromes. Mol Cell Biochem 244:143-150
23. Schulze A, Bachert P, Schlemmer H, Harting I, Polster T, Salomons GS, Verhoeven NM, Jakobs C, Fowler B, Hoffmann GF, Mayatepek E (2003) Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol 53:248-251 (Pubitemid 36164008)
24. Shaham D, Slate NG, Goldberger O, Xu Q, Ramanathan A, Souza AL, Clish CB, Sims KB, Mootha VK (2010) A plasma signature of human mitochondrial disease revealed through metabolic profiling of spend media from cultured muscle cells. Proc Nat Acad Sci USA 107:1571-1575
25. Stryer L (1995) Biochemistry. W.H. Freeman and Company, New York
26. Vickers AE (2009) Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors. Toxicol Pathol 37:78-88
27. Wang X, Gong CS, Tsao GT (1998) Production of L-malic acid via biocatalysis employing wild-type and respiratory-deficient yeasts. Appl Biochem Biotechnol 70-72:845-852 (Pubitemid 28361103)
28. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM (2006) Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78:4430-4442
29. Wishart DS (2008) Quantitative metabolomics using NMR. Trends Anal Chem 27:228-237
30. Xu Q, Sachs JR, Wang TC, Schaefer WH (2006) Quantification and identification of components in solution mixtures from 1D proton NMR spectra using singular value decomposition. Anal Chem 78:7175-7185 (Pubitemid 44607560)
31. Xu EY, Perlina A, Vu H, Troth SP, Brennan RJ, Aslamkhan AG, Xu Q (2008) Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. Chem Res Toxicol 21:1548-1561
32. Xu EY, Schaefer WH, Xu Q (2009) Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Curr Opin Drug Discov Devel 12:40-52